Hepatology
What they do most for Medicare patients
| Service, sort | Times billed, sort |
|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 34,723 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 21,918 |
| Established patient office or other outpatient visit, 40-54 minutes | 19,619 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 12,858 |
| Established patient office or other outpatient visit, 20-29 minutes | 8,760 |
| Pathology examination of tissue using a microscope, intermediate complexity | 7,670 |
| Measurement of liver stiffness | 7,028 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 5,823 |
| New patient office or other outpatient visit, 45-59 minutes | 5,611 |
| New patient office or other outpatient visit, 60-74 minutes | 3,817 |
| Special stained specimen slides to examine tissue including interpretation and report | 3,717 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 3,512 |
| Insertion of needle into vein for collection of blood sample | 3,494 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 2,721 |
| Complete ultrasound scan of abdomen | 2,322 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 2,068 |
| Special stained specimen slides to identify organisms including interpretation and report | 2,044 |
| Ultrasound scan of organ tissue for measuring elasticity | 1,987 |
| Biopsy of large bowel using a flexible endoscope | 1,865 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 1,655 |
| Glutamyltransferase (liver enzyme) level | 1,594 |
| Blood test, clotting time | 1,123 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 1,083 |
| Blood test, comprehensive group of blood chemicals | 1,038 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 983 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 938 |
| Magnesium level | 898 |
| New patient office or other outpatient visit, 30-44 minutes | 813 |
| Critical care, first 30-74 minutes | 782 |
| Ferritin (blood protein) level | 706 |
| Hospital discharge day management, 30 minutes or less | 620 |
| Liver function blood test panel | 618 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 602 |
| Alpha-fetoprotein (afp) level, serum | 597 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 567 |
| Telephone medical discussion with physician, 21-30 minutes | 522 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 520 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 458 |
| Telehealth originating site facility fee | 436 |
| Established patient office or other outpatient visit, 10-19 minutes | 411 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 386 |
| Gammaglobulin (immune system protein) measurement | 376 |
| Administration of hepatitis b vaccine | 347 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 322 |
| Hospital discharge day management, more than 30 minutes | 322 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 318 |
| Iron level | 300 |
| Iron binding capacity | 300 |
| Blood test, basic group of blood chemicals (calcium, total) | 289 |
| Telephone medical discussion with physician, 11-20 minutes | 288 |
| Detection of infectious agent antibody, quantitative | 286 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 280 |
| Diagnostic exam of large bowel using a flexible endoscope | 280 |
| Measurement of hepatitis a antibody | 278 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 239 |
| Detection test by immunoassay technique for hepatitis b surface antigen | 228 |
| Hepatitis c antibody measurement | 221 |
| Limited ultrasound scan of abdomen | 220 |
| Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | 206 |
| Dilation of esophagus | 204 |
| Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies | 188 |
| Ceruloplasmin (protein) level | 162 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 145 |
| Drainage of fluid from abdominal cavity using imaging guidance | 136 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 102 |
| Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | 101 |
| Drainage of fluid from abdominal cavity | 90 |
| Insulin measurement, total | 83 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 83 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 81 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 80 |
| Blood test, lipids (cholesterol and triglycerides) | 76 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 70 |
| Blood group typing (abo) | 69 |
| Blood typing for rh (d) antigen | 68 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 66 |
| Administration of influenza virus vaccine | 61 |
| Hemoglobin a1c level | 61 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 48 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 47 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 46 |
| Pathology examination of tissue using a microscope, moderately high complexity | 42 |
| Ultrasonic guidance for needle placement | 42 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 41 |
| Injection beneath lining of large bowel using a flexible endoscope | 40 |
| Critical care, each additional 30 minutes | 39 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 39 |
| Injection of drug or substance under skin or into muscle | 38 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 37 |
| Administration of chemotherapy into vein, each additional hour | 36 |
| Administration of chemotherapy into vein, 1 hour or less | 36 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 34 |
| Biopsy of lower large bowel using a flexible endoscope | 32 |
| Study of esophagus to assess movement | 32 |
| Administration of vaccine | 31 |
| Blood test, thyroid stimulating hormone (tsh) | 30 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 |
| Review by radiologist of image from tube placement into bile and pancreatic duct using an endoscope | 27 |
| Exam of common bile and/or pancreatic duct using a flexible endoscope | 27 |
| Bilirubin level, direct | 25 |
Sources: Medicare Care Compare (hospitals and schools; Medicare-enrolled clinicians), CMS Medicare Physician & Other Practitioners 2023 (services), Medicare Part D Prescribers 2024 (drugs).